CompaniesNovocell

Novocell

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

12

By Phase

PHASE1/PHASE2: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
Today
NCT00260234
Hover over trial bars to see details

Recent Trials

NCT00260234Lead Sponsor
Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients
PHASE1/PHASE2Terminated
12 participants
Started: Nov 30, 2005 · Completed: Dec 31, 2007
Funding History (1)
D
Mar 24, 2010
Filing